These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35879188)

  • 41. Look at the cognitive deficits in patients with myotonic dystrophy type 1: an exploratory research on the effects of virtual reality.
    Maresca G; Portaro S; Naro A; Scarcella I; Bramanti P; Militi D; Accorinti M; De Luca R; Calabrò RS
    Int J Rehabil Res; 2020 Mar; 43(1):90-94. PubMed ID: 31851022
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Brief assessment of cognitive function in myotonic dystrophy: Multicenter longitudinal study using computer-assisted evaluation.
    Deutsch GK; Hagerman KA; Sampson J; Dent G; Dekdebrun J; Parker DM; Thornton CA; Heatwole CR; Subramony SH; Mankodi AK; Ashizawa T; Statland JM; Arnold WD; Moxley RT; Day JW;
    Muscle Nerve; 2022 May; 65(5):560-567. PubMed ID: 35179228
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Addenbrooke's cognitive examination III: diagnostic utility for mild cognitive impairment and dementia and correlation with standardized neuropsychological tests.
    Matias-Guiu JA; Cortés-Martínez A; Valles-Salgado M; Rognoni T; Fernández-Matarrubia M; Moreno-Ramos T; Matías-Guiu J
    Int Psychogeriatr; 2017 Jan; 29(1):105-113. PubMed ID: 27682860
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Speech and language abnormalities in myotonic dystrophy: An overview.
    Hanoun S; Sun Y; Ebrahimi F; Ghasemi M
    J Clin Neurosci; 2022 Feb; 96():212-220. PubMed ID: 34789418
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The current clinical perception of myotonic dystrophy type 2.
    Kleefeld F; Schoser B
    Curr Opin Neurol; 2023 Oct; 36(5):474-478. PubMed ID: 37639480
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Cognitive impairment in myotonic dystrophy type 1 (Steinert's disease)].
    Rosado Bartolomé A; Puertas Martín V; Domínguez González C; Ramos Miranda M
    Semergen; 2022 Apr; 48(3):208-213. PubMed ID: 35292189
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Longitudinal Changes in Neuropsychological Functioning in Japanese Patients with Myotonic Dystrophy Type 1: A Five Year Follow-Up Study.
    Fujino H; Suwazono S; Ueda Y; Kobayashi M; Nakayama T; Imura O; Matsumura T; Takahashi MP
    J Neuromuscul Dis; 2023; 10(6):1083-1092. PubMed ID: 37599536
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical aspects, molecular pathomechanisms and management of myotonic dystrophies.
    Meola G
    Acta Myol; 2013 Dec; 32(3):154-65. PubMed ID: 24803843
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Psychological characteristics of patients with myotonic dystrophy type 1.
    Bertrand JA; Jean S; Laberge L; Gagnon C; Mathieu J; Gagnon JF; Richer L
    Acta Neurol Scand; 2015 Jul; 132(1):49-58. PubMed ID: 25496310
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Heart involvement in patients with myotonic dystrophy type 2.
    Peric S; Bjelica B; Aleksic K; Kovacevic M; Cvitan E; Mandic Stojmenovic G; Rakocevic Stojanovic V
    Acta Neurol Belg; 2019 Mar; 119(1):77-82. PubMed ID: 30536153
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Unravelling the impact of frontal lobe impairment for social dysfunction in myotonic dystrophy type 1.
    Morin A; Funkiewiez A; Routier A; Le Bouc R; Borderies N; Galanaud D; Levy R; Pessiglione M; Dubois B; Eymard B; Michon CC; Angeard N; Behin A; Laforet P; Stojkovic T; Azuar C
    Brain Commun; 2022; 4(3):fcac111. PubMed ID: 35611304
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recognition of emotions conveyed by facial expression and body postures in myotonic dystrophy (DM).
    Lenzoni S; Bozzoni V; Burgio F; de Gelder B; Wennberg A; Botta A; Pegoraro E; Semenza C
    Cortex; 2020 Jun; 127():58-66. PubMed ID: 32169676
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Disease awareness in myotonic dystrophy type 1: an observational cross-sectional study.
    Baldanzi S; Bevilacqua F; Lorio R; Volpi L; Simoncini C; Petrucci A; Cosottini M; Massimetti G; Tognoni G; Ricci G; Angelini C; Siciliano G
    Orphanet J Rare Dis; 2016 Apr; 11():34. PubMed ID: 27044540
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparisons of intellectual capacities between mild and classic adult-onset phenotypes of myotonic dystrophy type 1 (DM1).
    Jean S; Richer L; Laberge L; Mathieu J
    Orphanet J Rare Dis; 2014 Nov; 9():186. PubMed ID: 25424323
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characterizing cognitive-motor impairments in patients with myotonic dystrophy type 1.
    Filli L; Schwegler S; Meyer C; Killeen T; Easthope CS; Broicher SD; Curt A; Zörner B; Bolliger M; Jung HH; Petersen JA
    Neuromuscul Disord; 2020 Jun; 30(6):510-520. PubMed ID: 32527589
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hydrocephalus and cognitive decline in myotonic dystrophy: case report and literature review.
    Moroz A; Kalva S
    Arch Phys Med Rehabil; 1998 Aug; 79(8):1022-3. PubMed ID: 9710180
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Peripheral nerve involvement in myotonic dystrophy type 2 - similar or different than in myotonic dystrophy type 1?
    Nojszewska M; Łusakowska A; Szmidt-Salkowska E; Gaweł M; Lipowska M; Sułek A; Krysa W; Rajkiewicz M; Seroka A; Kaczmarek K; Kamińska AM
    Neurol Neurochir Pol; 2015; 49(3):164-70. PubMed ID: 26048604
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cognitive screening in substance users: Diagnostic accuracies of the Mini-Mental State Examination, Addenbrooke's Cognitive Examination-Revised, and Montreal Cognitive Assessment.
    Ridley N; Batchelor J; Draper B; Demirkol A; Lintzeris N; Withall A
    J Clin Exp Neuropsychol; 2018 Mar; 40(2):107-122. PubMed ID: 28436744
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of temporal and stride characteristics in myotonic dystrophies type 1 and 2 during dual-task walking.
    Radovanović S; Perić S; Savić-Pavićević D; Dobričić V; Pešović J; Kostić V; Rakočević-Stojanović V
    Gait Posture; 2016 Feb; 44():194-9. PubMed ID: 27004657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.